NGM BIOPHARMACEUTICALS INC Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NGM BIOPHARMACEUTICALS INC for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.50 | 50,000 | 675,000 | 15,759,014 | 15.7 M to 15.8 M (+0.32 %) |
| May 22 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.50 | 50,000 | 675,000 | 15,569,014 | 15.5 M to 15.6 M (+0.32 %) |
| May 22 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.50 | 50,000 | 675,000 | 1,999,923 | 1.9 M to 2 M (+2.56 %) |
| May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
| May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
| May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
| May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Hooper Suzanne Sawochka | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
| May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Hooper Suzanne Sawochka | Director | Option Exercise | A | 13.35 | 38,000 | 507,300 | 38,000 | |
| May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
| May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
| May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.85 | 17,923 | 248,234 | 15,709,014 | 15.7 M to 15.7 M (+0.11 %) |
| May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.85 | 17,923 | 248,234 | 15,519,014 | 15.5 M to 15.5 M (+0.12 %) |
| May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.85 | 17,923 | 248,234 | 1,949,923 | 1.9 M to 1.9 M (+0.93 %) |
| May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.85 | 17,923 | 248,234 | 1,949,923 | 1.9 M to 1.9 M (+0.93 %) |
| May 09 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.10 | 57,000 | 803,700 | 15,691,091 | 15.6 M to 15.7 M (+0.36 %) |
| May 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.10 | 57,000 | 803,700 | 15,501,091 | 15.4 M to 15.5 M (+0.37 %) |
| May 09 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 14.10 | 57,000 | 803,700 | 1,932,000 | 1.9 M to 1.9 M (+3.04 %) |